Table 1.

Characteristics of the patient's cohort used for this study

Patient code	Age (yr)	Gender	Type of infection a	Days of disease b	Severe DENV (WS/NWS) c	qRT‐PCR DENV	NS1 DENV	IgM DENV	IgM CHIKV	qRT‐PCR ZIKV	Platelets/mm3	Leukocytes/mm3	Lymphocytes/mm3
DENV
1	39	Male	Secondary	4	No (NWS)	DENV‐1	pos	neg	neg	neg	248	4400	2464
2	47	Female	Secondary	22	No (WS)	DENV‐1 d	neg	pos	neg	neg	117	–	–
3	69	Male	Secondary	3	No (WS)	DENV‐1	pos	pos	neg	neg	98	2200	–
4	27	Female	Secondary	2	No (NWS)	DENV‐4	neg	neg	neg	neg	209	7800	1248
5	52	Female	Primary	3	No (NWS)	DENV‐1	pos	neg	neg	neg	163	3400	272
6	30	Female	Secondary	6	No (NWS)	neg	pos	pos	neg	neg	172	2700	575
Median [IQR]	43 [29–56]			4 [3–10]							168 [112–219]	3400 [2450–6100]	912 [348–2160]
ZIKV
7	38	Female	Secondary	5		neg	neg	neg	neg	pos	197	3900	1521
8	28	Male	Primary	4		neg	neg	neg	neg	pos	128	3800	1330
9	45	Male	Secondary	3		neg	neg	neg	neg	pos	246	4000	1640
10	60	Female	Secondary	4		neg	neg	neg	neg	pos	289	6100	3416
Median [IQR]	42 [31–56]			4 [3–5]							222 [145–278]	3950 [3825–5575]	1581 [1378–2972]
DENV/ZIKV
11	14	Male	Primary	2	No (NWS)	neg	pos	neg	neg	pos	260	4600	2024
12	46	Male	Secondary	5	No (NWS)	neg	pos	neg	neg	pos	151	5300	2120
13	19	Female	Secondary	8	No (NWS)	DENV‐1	inconcl	neg	neg	pos	296	9900	2871
14	33	Female	Secondary	8	No (NWS)	DENV‐1	neg	neg	neg	pos	239	6600	1848
15	21	Female	Secondary	4	No (NWS)	DENV‐1	neg	neg	neg	pos	137	4700	2585
16	48	Male	Primary	3	No (NWS)	DENV‐4	pos	neg	neg	pos	147	3000	870
17	18	Male	Secondary	2	No (NWS)	DENV‐1	neg	pos	neg	pos	308	6000	780
Median [IQR]	21 [18–46]			4 [2–8]							239 [147–296]	5300 [4600–6600]	2024 [870–2585]

– Data not available.

^aPerformed by the IgG DENV.

^bDays after the initial symptoms.

^cWS/NWS, dengue fever with warning signs/dengue fever without warning signs.

^dPatient 2 confirmed DENV‐1 infection using Simplexa™ Dengue Real Time RT‐PCR (Focus Diagnostics, Cypress, CA) (CT = 34) even after 22 days of onset of symptoms.